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Abstract
Background
Dyslipidemia is a leading risk factor for atherosclerotic cardiovascular disease. There are
few published epidemiological data regarding dyslipidemia in Africa. We determined full lipid
and apolipoprotein profiles and investigated factors associated with lipid levels in urban and
rural populations of north-western Tanzania and southern Uganda.
Methods
We conducted a cross-sectional survey of randomly-selected, community-dwelling adults
(�18yrs) including five strata per country: one municipality, two district towns and two rural
areas. Participants were interviewed and examined using the World Health Organization
STEPwise survey questionnaire. Serum levels of total cholesterol, low-density lipoprotein
cholesterol, high-density lipoprotein cholesterol, triglycerides, and apolipoproteins were
measured. Factors associated with mean lipid levels were assessed by multivariable linear
regression. Framingham 10-year cardiovascular risk scores were calculated with and with-
out lipids.
Results
One-third of adults in the study population had dyslipidemia. Low high-density lipoprotein
cholesterol affected 32–45% of rural adults. High total cholesterol, low-density lipoprotein
cholesterol, and apolipoprotein B were found in <15% of adult population in all strata, but
were more common in urban adults. Factors independently associated with higher mean
low-density lipoprotein cholesterol and apolipoprotein B were female gender, older age,
PLOS ONE | https://doi.org/10.1371/journal.pone.0223189 December 6, 2019 1 / 16
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPEN ACCESS
Citation: Kavishe B, Vanobberghen F, Katende D,
Kapiga S, Munderi P, Baisley K, et al. (2019)
Dyslipidemias and cardiovascular risk scores in
urban and rural populations in north-western
Tanzania and southern Uganda. PLoS ONE 14(12):
e0223189. https://doi.org/10.1371/journal.
pone.0223189
Editor: Joel Msafiri Francis, University of the
Witwatersrand, SOUTH AFRICA
Received: March 14, 2019
Accepted: September 16, 2019
Published: December 6, 2019
Copyright: © 2019 Kavishe et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information
files.
Funding: This study was jointly funded by the
Medical Research Council (MRC; grant id-nu.
99430 provided to HG) and the UK Department for
International Development (DFID) under the MRC/
DFID Concordat and was also part of the EDCTP
Programme supported by the European Union. The
funders had no role in study design, data collection
higher education, higher income, obesity, and hypertension. Framingham cardiovascular
risk scores with and without lipids yielded similar results and 90% of study subjects in all
strata were classified as “low risk”. Among older adults (>55 years), 30% were classified as
“high” or “very high” risk.
Conclusions
Dyslipidemias are common among adults in north-western Tanzania and southern Uganda
affecting one third of adult population. Overall, cardiovascular risk scores are low but high
risk scores are common with older adults. Health services designed and equipped to diag-
nose and treat dyslipidemia are urgently needed.
Introduction
Dyslipidemia is a major modifiable risk factor for morbidity and mortality worldwide, particu-
larly as a cause of ischemic heart disease and stroke [1, 2]. According to the most recent global
burden of diseases study, there were 4.3 million deaths in 2015 that were attributable to dyslipi-
demia, making this the 7th leading risk factor for disability-adjusted life years [3]. Although
dyslipidemia was traditionally considered a “disease of affluence”, there is a growing recogni-
tion that dyslipidemia is also common in low-income regions such as sub-Saharan Africa
(SSA) [1, 4, 5].
Little is known about the epidemiology of dyslipidemia in SSA. Findings from few pub-
lished hospital-based studies [1, 5, 6] may not be representative of the general population.
Although several community-based studies on dyslipidemia have been published from SSA
[7–16], none of these have included more than one country and few have included both urban
and rural areas [11–13]. Moreover, few studies conducted in this region measured full lipid
profile including apolipoproteins [14–16].
To contribute data which may help to describe the patterns of dyslipidemia and cardiovas-
cular risk in SSA, we conducted this study to determine full lipid and apolipoprotein profiles
and investigate factors associated with lipid levels in urban and rural populations of north-
western Tanzania and southern Uganda. We also determined 10-year cardiovascular risk
according to the Framingham risk score, with and without lipids. Results from this study may
help to guide public health efforts for prevention of cardiovascular diseases in SSA.
Materials and methods
Study design and sampling
We conducted a cross-sectional population-based survey among adults aged�18 years in
north-western Tanzania and southern Uganda from May 2012 to April 2013. As previously
described [17], we used stratified, multistage sampling, including five strata per country: a
municipal area (Mwanza city in Tanzania; Entebbe town in Uganda), two district towns (Geita
and Kahama in Tanzania; Wakiso and Mpigi in Uganda) and two rural areas corresponding to
the respective district towns.
Description of the study area
Mwanza is the second largest commercial city in Tanzania with a population of approximately
710,000 [18]. Entebbe is mainly an administrative town with a population of approximately
Dyslipidemia and cardiovascular risk scores
PLOS ONE | https://doi.org/10.1371/journal.pone.0223189 December 6, 2019 2 / 16
and analysis, decision to publish, or preparation of
the manuscript.
Competing interests: The authors have declared
that no competing interests exist.
70,000 [19]. Kahama, Geita and Mpigi districts are predominantly rural, with a population of
approximately 960,000 in Geita, 770,000 in Kahama and 250,000 in Mpigi [18, 19]. Wakiso dis-
trict is comprised of urban, peri-urban and rural areas and has a population of around 2 mil-
lion. Mwanza and Entebbe municipalities’ economy depends mainly on medium to large
income businesses. The main economic activities in the district towns and rural areas are small
entrepreneurship, subsistence farming and fishing.
Sample size
As previously described [17], the survey was designed to measure the prevalence of selected
chronic diseases for intervention planning. We visited 540 randomly selected households to
enroll the target sample size of 950 participants per country.
Study procedures
Data collection was conducted by trained clinicians and nurses at participants’ homes or
nearby communal places. Participants were interviewed using a structured questionnaire
adapted from the World Health Organization (WHO) STEPwise approach to chronic disease
risk factor surveillance (STEPS) instrument [20]. We collected information on socio-demo-
graphic characteristics and risk factors for non communicable diseases, including alcohol con-
sumption using a standardized screening questionnaire (Alcohol Use Disorders Identification
Test, AUDIT) [21]. We conducted a physical examination to determine weight, height, body
mass index (BMI) and blood pressure (BP) as previously described [17]. In summary, weight
was measured using digital seca1 813 scale and height using a seca1 213 stadiometer. BP was
measured using the Omron digital automatic blood pressure monitor model M6 (Omron
Health Care Manufacturing Vietnam Co., Ltd, Binh Duong Province, Vietnam).
During the first visit, we collected non-fasting blood samples for determination of serum
levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipo-
protein cholesterol (HDL-C), triglycerides, apolipoprotein A1 (apoA1) and apolipoprotein B
(apoB) and for HIV and random blood glucose (RBG) tests. Participants found with elevated
RBG (�7mmol/l) were given instructions to fast overnight and a follow up visit was arranged
to collect fasting blood glucose (FBG) samples.
In Tanzania, serum aliquots for lipid testing were stored in a portable freezer (-20˚C) in the
field and transported within five days to the National Institute for Medical Research laboratory
in Mwanza municipality where they were stored at -80˚C. About two months later, serum
samples from Tanzania were transported to the Medical Research Council/Uganda Virus
Research Institute (MRC/UVRI) and London School of Hygiene and Tropical Medicine labo-
ratory in Entebbe, Uganda for testing. In Uganda, serum aliquots from the field were trans-
ported within 10 hours in a cold box to the MRC/UVRI and London School of Hygiene and
Tropical Medicine laboratory where they were immediately stored at -80˚C until testing.
Laboratory methods
Serum lipid and apolipoprotein levels were measured using the Cobas Integra 400 Plus ana-
lyzer (Roche, Basel, Switzerland) with Roche ‘closed’ reagents (Roche, Manheim, Germany).
HDL-C and LDL-C were each directly measured with homogeneous colorimetric assays using
HDL-C plus 3rd generation and LDL-C plus 2nd generation reagents. Triglycerides and TC
were measured using an enzymatic colorimetric assay (triglyceride and TC generation 2
reagents), and apoA1 and apoB levels by an immunoturbidimetric assay (Tina-quant version 2
reagents). External quality assurance for apoA and apoB was conducted by the College of
American Pathologists. The MRC/UVRI and London School of Hygiene and Tropical
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Medicine laboratory, where all lipid assays were performed, has been certified for good clinical
laboratory practice since 2009.
As previously reported [17] we tested venous blood samples in the field for RBG using
Accu-Check1 Aviva (Roche Diagnostics GmbH, Mannheim, Germany) and FBG using
HemoCue1 Glucose 201 RT (HemoCue AB, A¨ngelholm, Sweden).
Definitions
We defined abnormal lipid levels based on the Adult Treatment Panel III criteria [22] as fol-
lows: high TC (�6.2 mmol/L), high LDL-C (�4.1 mmol/L), low HDL-C (<1 mmol/L) and
high triglycerides (�2.26 mmol/L). High TC/HDL-C ratio was defined as>6.4 for men and
>5.6 for women [23]. High apoB (females >4.43 Umol/L and males>5.04 Umol/L) and low
apoA1 (females <1.08 Umol/L and males < 1.04 Umol/L) were defined according to the pack-
age insert [24, 25]. Dyslipidaemia was defined as abnormal TC, LDL-C, HDL-C, triglyceride
and/or apoB levels.
Hypertension was defined as systolic BP�140 mmHg and/or diastolic BP�90 mmHg, or
currently taking medication for hypertension. Diabetes mellitus was defined as RBG >11.1
mmol/L, or FBG�7 mmol/L, or being on diabetes medication. HIV infection was diagnosed
based on the national testing algorithms as previously described [17]. BMI (kg/m2) was classi-
fied as underweight (<18.5), normal weight (18.5-<25), overweight (25-<30) and obese
(�30). Abdominal obesity was defined as waist circumference >94 cm for men and>80 cm
for women [26].
The 10-year cardiovascular risks were calculated using the Framingham risk calculator as
recommended by current WHO and South African guidelines [27, 28]. We used two versions
of this Framingham risk calculator for the sake of comparison, one with lipid values and one
without [29]. Age, sex, diabetes, smoking, systolic BP and whether or not on hypertensive
treatment are used in both calculations. TC and HDL-C were used in the calculation with lipid
results; BMI was used in the calculation without lipid results. Cardiovascular risk scores were
categorized as low risk (<10%) intermediate risk (10–19%), and high risk (�20%) as recom-
mended by the WHO [28].
Statistical analysis
Data were captured using Ultra Mobile Personal Computers in Uganda and paper-based ques-
tionnaires in Tanzania as described previously [17]. Analyses were conducted using Stata Ver-
sion 11 (Stata Corporation, College Station, USA). We used Stata survey procedures for all
analyses to account for the complex sampling design, with sampling weights to account for dif-
ferential probability of selection within strata.
We included participants for whom we had any lipids data. We tabulated the characteristics
of the survey population, prevalence of dyslipidemias and Framingham 10-year cardiovascular
risk scores stratified by country and location (municipalities, district towns, and rural areas),
using weighted percentages and 95% confidence intervals (CI), and observed (i.e. unweighted)
frequencies. Blood lipid distributions were summarized similarly using weighted means and
95% CI. Framingham 10-year cardiovascular risk scores were also analyzed stratified by age
groups.
We investigated factors associated with higher LDL-C levels combining data from both
countries and using linear regression. Potential determinants of LDL-C were examined using
a conceptual framework [30], with four levels (sociodemographic, behavioural, anthropomet-
ric and chronic disease factors). Stratum, age and sex were considered a priori confounders so
were included in all models, therefore comparisons were essentially within the (approximately
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self-weighted) strata and sampling weights were not applied. Socio-demographic factors were
added to the stratum, age and sex-adjusted models and retained if associated with LDL-C at
p<0.1. Behavioural factors were then added one by one and retained if they remained associ-
ated at p<0.1. Associations with anthropometric and chronic disease factors were subse-
quently determined in a similar way. This strategy allowed us to assess the effects of variables
at each level of the framework, adjusted for variables that are more distal. In reporting, we
focus on variables with associations that were statistically significant at p-values of<0.05. Sim-
ilar analyses were performed for HDL-C, apoA1 and apoB. We performed a sensitivity analysis
to investigate factors associated with abnormally high LDL-C, high apoB and low HDL-C
using logistic regression. This analysis yielded results similar to those from the linear regres-
sions. We also determined the correlation between apoA1 and HDL-C levels as well as apoB
and LDL-C levels using Pearson’s correlation coefficients.
Ethical considerations
The population survey was approved by the Ugandan National Council for Science and Tech-
nology and by the ethics committees of the Tanzanian National Institute for Medical Research,
the UVRI, and the London School of Hygiene and Tropical Medicine. We obtained written
informed consent (witnessed for illiterate participants) from all participants before administer-
ing study procedures. Participants diagnosed with any medical condition during the survey
were referred to the nearest public health facility for follow-up care. Those diagnosed with dys-
lipidemia or high Framingham 10-year cardiovascular risk scores were not referred because
lipid-lowering drugs were then not available in the health care system for both countries.
Results
Lipids data were missing for 52 Tanzania and 2 Uganda participants, leaving 1043 Tanzania
and 914 Uganda participants included in the analysis. Of the 54 total participants with missing
data: 49 refused blood collection, venipuncture failed in 4 and 1 could not complete study pro-
cedures due to a personal emergency.
Population characteristics
Population characteristics are presented in Table 1, by location (municipal, district town,
rural) and country, and these have been described in detail previously [17]. The median age
ranged from 28 to 35 years and was highest in rural areas in both Tanzania and Uganda. The
study population comprised more women (52–62%) than men across all strata. The prevalence
of overweight or obesity, as determined by BMI, was 28–35% in Uganda and 11–27% in Tan-
zania and was lower in rural areas.
Population distribution of serum lipids
Table 2 shows the lipid levels and ratios by location and country. Mean TC, LDL-C, HDL-C,
apoA1 and apoB levels were highest in municipal areas and lowest in rural populations, with
small differences between the countries. LDL-C/HDL-C, apoB/HDL-C, TC/HDL-C and apoB/
apoA1 ratios were generally similar across strata in both countries.
Prevalence of dyslipidemia
Prevalence of dyslipidemia is presented in Table 3. The overall prevalence of dyslipidemia in
Tanzania was 30% in Mwanza municipality, 29% in district towns and 50% in rural areas, and
in Uganda was 32% in both Entebbe municipality and district towns, and 44% in rural areas.
Dyslipidemia and cardiovascular risk scores
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Table 1. Characteristics of the study population.
Weighted %1 (95%
CI)2
Unweighted n3 Weighted %1 (95%
CI)2
Unweighted n3 Weighted %1 (95%
CI)2
Unweighted n3
TANZANIA Mwanza municipality (n = 170) District towns (n = 326) Rural areas (n = 547)
Age
Weighted median (IQR)4 29 (22–41) 170 28 (23–37) 326 34 (24–49) 547
Sex
Male 42.5% (34.8–50.7) 72 44.6% (38.1–51.3) 145 47.8% (43.7–51.9) 260
Female 57.5% (49.3–65.2) 98 55.4% (48.7–61.9) 181 52.2% (48.1–56.3) 287
Level of education
None/incomplete primary 21.8% (14.9–30.8) 34 21.0% (15.7–27.4) 70 48.2% (40.6–55.9) 257
Primary 47.9% (43.3–52.5) 82 50.6% (45.4–55.8) 163 43.7% (37.9–49.7) 246
Secondary or above 30.3% (24.7–36.6) 54 28.4% (21.5–36.5) 93 8.1% (5.2–12.4) 44
Smoking status
Current 8.7% (3.6–19.7) 15 7.7% (4.0–14.6) 26 12.3% (9.4–16.0) 67
Ex-smoker 6.0% (2.3–14.6) 9 8.3% (4.8–13.9) 25 7.9% (5.8–10.6) 45
Never 85.3% (73.2–92.5) 146 84.0% (78.2–88.4) 275 79.8% (76.3–82.9) 435
Alcohol consumption5
Never drinker 68.4% (59.4–76.1) 118 58.4% (51.3–65.2) 192 65.7% (59.3–71.6) 359
Ex-drinker 12.3% (8.8–16.9) 21 25.7% (20.6–31.4) 80 24.0% (19.6–29.2) 136
Healthy drinker6 3.9% (2.1–7.2) 7 4.4% (2.5–7.7) 14 4.8% (2.3–9.7) 21
Unhealthy drinker 15.5% (11.1–21.2) 24 11.5% (7.8–16.7) 38 5.5% (3.3–8.9) 31
Eats at least 1 serving of fruit/vegetable per
day7
No 28.5% (19.2–40.1) 42 25.2% (17.6–34.7) 63 37.3% (27.6–48.2) 145
Yes 71.5% (59.9–80.8) 104 74.8% (65.3–82.4) 185 62.7% (51.8–72.4) 251
Body Mass Index (BMI) category (kg/m2)8
Under weight (<18.5) 13.0% (9.8–17.0) 22 6.9% (4.0–11.8) 22 12.7% (9.9–16.1) 65
Normal weight (18.5 - <25) 61.5% (55.5–67.2) 105 66.3% (59.3–72.6) 218 76.0% (71.1–80.4) 414
Overweight (25 - <30) 17.8% (13.8–22.7) 29 13.3% (10.7–16.3) 43 8.8% (6.2–12.3) 51
Obese (�30) 7.7% (5.3–11.0) 13 13.6% (9.1–19.8) 43 2.5% (1.3–4.8) 13
Abdominal obesity9 28.9% (23.5–34.9) 47 31.7% (24.0–40.5) 102 19.4% (15.4–24.2) 110
UGANDA Entebbe municipality (n = 205) District towns (n = 278) Rural areas (n = 431)
Age
Weighted median (IQR)4 29 (22–39) 205 28 (22–37) 278 35 (24–49) 431
Sex
Male 38.5% (33.9–43.4) 79 41.0% (34.4–48.1) 108 42.6% (37.5–48.0) 188
Female 61.5% (56.6–66.1) 126 59.0% (51.9–65.6) 170 57.4% (52.0–62.5) 243
Level of education
None/incomplete primary 17.6% (9.8–29.5) 36 22.2% (18.4–26.4) 67 42.4% (32.7–52.8) 198
Primary 12.2% (6.8–20.8) 25 11.7% (6.3–20.6) 34 18.5% (15.5–22.1) 83
Secondary or above 70.2% (59.3–79.3) 144 66.2% (57.5–73.8) 177 39.0% (30.4–48.4) 150
Smoking status10
Current 7.8% (3.6–16.0) 16 6.9% (4.4–10.6) 15 8.7% (5.3–13.9) 39
Ex-smoker 8.3% (5.0–13.4) 17 5.2% (3.1–8.4) 14 9.2% (7.1–11.9) 39
Never 83.9% (73.7–90.6) 172 87.9% (83.2–91.5) 248 82.1% (75.4–87.3) 353
Alcohol consumption
Never drinker 32.2% (26.2–38.8) 66 45.6% (38.4–52.9) 121 38.4% (31.5–45.8) 166
Ex-drinker 23.4% (15.2–34.3) 48 22.6% (18.2–27.7) 63 23.5% (18.0–30.1) 103
Healthy drinker6 33.7% (27.5–40.4) 69 25.7% (20.2–32.0) 83 33.5% (25.2–43.1) 142
(Continued)
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Low HDL-C was the most common dyslipidemia, particularly in rural populations (Tanzania
45%; Uganda 32%). The proportion of the population with high LDL-C was highest in munici-
pal areas (Mwanza 9%; Entebbe 5%) and lowest in rural populations (rural Tanzania 1%; rural
Uganda 3%). The prevalence of high apoB was also highest in municipal areas (Mwanza 10%;
Entebbe 15%).
Across all strata, 24% of the population had low HDL-C without any other lipid or apoli-
protein abnormalities (S1 Table). All other dyslipidemias commonly occurred in clusters of 2
or 3 abnormalities. LDL-C levels were strongly and positively correlated with apoB levels
(Pearson’s correlation coefficient = 0.87); and HDL-C levels were strongly correlated with
apoA1 levels (Pearson’s correlation coefficient = 0.79).
Factors associated with lipid levels
Factors associated with high LDL-C and apoB. Table 4 displays factors associated with
mean LDL-C and apoB levels. Factors significantly associated with higher mean LDL-C were
female gender, older age, higher education, formal employment, higher monthly income,
more items owned, tap water in the house compound, never having smoked, higher BMI,
abdominal obesity, being HIV negative and having elevated BP levels. Factors significantly
associated with higher mean apoB levels were nearly identical to those associated with higher
mean LDL-C levels except that formal employment and HIV were not significantly associated
with higher mean apoB but using a vehicle as the usual mode of transport was significantly
associated with higher mean apoB.
Table 1. (Continued)
Weighted %1 (95%
CI)2
Unweighted n3 Weighted %1 (95%
CI)2
Unweighted n3 Weighted %1 (95%
CI)2
Unweighted n3
Unhealthy drinker 10.7% (5.9–18.7) 22 6.2% (3.9–9.7) 11 4.5% (2.7–7.5) 20
Eats at least 1 serving of fruit/vegetable per
day
No 44.9% (34.6–55.6) 92 58.8% (51.9–65.5) 182 66.4% (60.1–72.2) 293
Yes 55.1% (44.4–65.4) 113 41.2% (34.5–48.1) 96 33.6% (27.8–39.9) 138
Body Mass Index (BMI) category (kg/
m2)11
Under weight (<18.5) 2.0% (0.7–5.7) 4 4.1% (1.5–10.6) 16 12.2% (8.6–17.2) 56
Normal (18.5 - <25) 67.0% (58.7–74.4) 134 61.3% (54.7–67.6) 172 60.1% (53.2–66.7) 266
Overweight (25 - <30) 19.0% (14.1–25.1) 38 22.9% (18.2–28.4) 60 20.1% (16.5–24.3) 79
Obese (�30) 12.0% (7.4–18.8) 24 11.6% (8.0–16.6) 27 7.5% (5.3–10.6) 29
Abdominal obesity9,12 27.5% (19.9–36.6) 56 31.4% (23.4–40.7) 87 27.4% (22.9–32.6) 109
1Weighted estimates, adjusted for survey design with sampling weights applied because the probability of being sampled differed within the strata.
295% confidence interval.
3Actual number of participants without sampling weights applied.
4Interquartile range.
5Alcohol consumption results are missing for 2 district town participants.
6Not more than 2 alcoholic drinks for female or not more than 3 alcoholic drinks for male per day.
7Fruit and vegetable intake results are missing for 24 Mwanza municipality, 78 district town and 151 rural participants.
8BMI category results are missing for 1 Mwanza municipality and 4 rural participants.
9Defined as waist circumference >94 cm for men and >80 cm for women.
10Smoking status results are missing for 1 district town participant.
11BMI category results are missing for 5 Entebbe municipality, 3 district town and 1 rural participant.
12Waist circumference results are missing for 1 Entebbe municipality and 2 district town participants.
https://doi.org/10.1371/journal.pone.0223189.t001
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Factors associated with low HDL-C and apoA1. Table 4 also displays factors associated
with mean HDL-C and apoA1 levels. Factors significantly associated with lower mean HDL-C
levels were female gender, younger age, being single, lower level of education, less alcohol con-
sumption, higher BMI, being HIV-infected (off treatment) and not having hypertension. All of
the factors associated with lower mean apoA1 levels were among those significantly associated
with lower mean HDL-C levels except lower level of education and BMI category.
Table 2. Population distribution of total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-
density lipoprotein cholesterol (LDL-C), triglyceride, apolipoprotein A1 (apoA1) and apolipoprotein B (apoB);
and apoB/apoA1, LDL-C/HDL-C, apoB/HDL-C and TC/HDL-C ratios.
Weighted mean1
(95% CI)2
Weighted mean1
(95% CI)2
Weighted mean1
(95% CI)2
P-value5
TANZANIA Mwanza
municipality
(n = 170)
District towns
(n = 326)
Rural areas
(n = 547)
TC (mmol/L) 4.72 (4.48–4.96) 4.42 (4.26–4.59) 3.85 (3.69–4.01) <0.001
LDL-C (mmol/L) 2.76 (2.60–2.91) 2.49 (2.35–2.63) 2.02 (1.91–2.14) <0.001
apoB (g/L)3 0.85 (0.81–0.89) 0.81 (0.77–0.86) 0.74 (0.71–0.77) <0.001
HDL-C (mmol/L) 1.39 (1.35–1.43) 1.22 (1.18–1.27) 1.01 (0.93–1.09) <0.001
apoA1 (g/L)3 1.58 (1.51–1.65) 1.43 (1.39–1.47) 1.30 (1.d24-1.35) <0.001
Triglycerides (mmol/
L)
1.05 (0.96–1.14) 1.09 (1.02–1.16) 1.17 (1.09–1.25) 0.12
apoB/apoA1 ratio3 0.56 (0.53–0.59) 0.58 (0.55–0.61) 0.59 (0.57–0.61) 0.24
LDL-C/HDL-C ratio 2.15 (2.03–2.28) 2.20 (2.04–2.36) 2.22 (2.12–2.32) 0.45
apoB/HDL-C ratio (g/
mmol)3
0.68 (0.65–0.71) 0.73 (0.67–0.78) 0.91 (0.82–1.01) <0.001
TC/HDL-C ratio 3.66 (3.50–3.81) 3.87 (3.65–4.09) 4.43 (4.11–4.75) <0.001
Non HDL cholesterol 3.33 (3.11–3.54) 3.20 (3.03–3.37) 2.84 (2.74–2.93) <0.001
UGANDA Entebbe
municipality
(n = 205)
District towns
(n = 278)
Rural areas
(n = 431)
TC (mmol/L) 4.57 (4.40–4.73) 4.35 (4.21–4.49) 4.05 (3.82–4.27) <0.001
LDL- C (mmol/L) 2.62 (2.48–2.75) 2.50 (2.38–2.62) 2.24 (2.05–2.43) 0.001
apoB (g/L)4 0.91 (0.84–0.98) 0.89 (0.85–0.93) 0.84 (0.78–0.91) 0.06
HDL-C (mmol/L) 1.41 (1.32–1.50) 1.28 (1.23–1.32) 1.16 (1.09–1.23) <0.001
apoA1 (g/L)4 1.49 (1.38–1.61) 1.41 (1.36–1.46) 1.41 (1.35–1.46) 0.22
Triglycerides (mmol/
L)
1.27 (1.02–1.52) 1.27 (1.12–1.42) 1.24 (1.15–1.34) 0.79
apoB/apoA1 ratio4 0.67 (0.57–0.76) 0.67 (0.62–0.73) 0.63 (0.57–0.69) 0.46
LDL-C/HDL-C ratio 2.04 (1.88–2.20) 2.10 (1.99–2.20) 2.14 (2.00–2.29) 0.72
apoB/HDL-C ratio (g/
mmol)4
0.74 (0.65–0.83) 0.77 (0.71–0.83) 0.83 (0.76–0.91) 0.33
TC/HDL-C ratio 3.53 (3.35–3.72) 3.63 (3.48–3.78) 3.86 (3.63–4.09) 0.10
Non HDL cholesterol 3.15 (3.00–3.31) 3.08 (2.95–3.21) 2.89 (2.71–3.07) 0.01
1Weighted estimates adjusted for survey design with sampling weights applied because the probability of being
sampled differed within the strata.
295% confidence interval.
3apoA1 and apoB (and hence their ratios) results are missing for 1 rural participant.
4apoA1 and apoB (and hence their ratios) results are missing for 1 Entebbe municipality, 4 district town and 14 rural
participants.
5p-values were calculated using unweighted data by linear regression (Wald test) with each lipid level as the outcome
and location as a categorical variable.
https://doi.org/10.1371/journal.pone.0223189.t002
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Framingham cardiovascular risk scores
Table 5 displays the Framingham 10-year cardiovascular risk scores calculated with and with-
out lipid values. Categorization of 10-year cardiovascular risk scores was generally similar
between the scores with and without lipids, with the proportion of the population classified as
intermediate and high risk being within 9–20% in each country and strata. The proportion of
the population with high risk scores (without lipids) was generally lower in urban areas (Tan-
zania 5.6%; Uganda 5.5%) and higher in rural areas (Tanzania 7.1%; Uganda 11.2%).
We also calculated Framingham 10-year cardiovascular risk scores (without lipid values) by
age category in the overall study population. Among those aged<35 years, all 1162 partici-
pants were categorised as low risk by Framingham. Among those aged 35–44 years, 12/326
(3.7%) and 2/326 (0.6%) were intermediate and high risk, respectively. The corresponding fig-
ures among those aged 45–55 years were 63/237 (26.6%) and 13/237 (5.5%); and among 55
+ years were 80/267 (30.0%) and 126/267 (47.2%). Of note, in the 55+ years group, 72/267 par-
ticipants (30.0%) had 10-year cardiovascular risk scores of>30% compared to only 4 individu-
als in all other groups combined.
Table 3. Prevalence of dyslipidaemia.
Weighted %1 (95% CI)2 n3 Weighted %1 (95% CI)2 n3 Weighted %1 (95% CI)2 n3 P-value4
TANZANIA Mwanza municipality
(n = 170)
District towns (n = 326) Rural areas (n = 547)
High TC (�6.2 mmol/L) 14.4% (9.1–22.0) 24 5.6% (3.6–8.5) 19 2.6% (1.5–4.5) 13 <0.001
High LDL-C (�4.1 mmol/L) 9.2% (5.3–15.3) 15 4.1% (2.6–6.4) 14 0.9% (0.4–2.1) 5 <0.001
High apoB5 9.8% (5.8–16.0) 16 7.8% (4.5–13.3) 25 4.8% (3.2–6.9) 29 0.22
Low HDL-C (<1 mmol/L) 15.3% (12.1–19.0) 26 20.6% (15.4–26.9) 67 44.7%(35.9–53.8) 250 <0.001
High triglycerides (�2.26 mmol/L) 3.6% (2.1–6.3) 6 6.3% (4.6–8.6) 21 5.9% (3.5–9.9) 30 0.21
High TC/HDL-C ratio (males >6.4 and females >5.6) 8.1% (5.1–12.7) 14 8.7% (5.1–14.3) 28 13.1% (10.1–16.7) 74 0.07
Any dyslipidaemia 6,7 29.7% (25.7–34.1) 50 29.1% (23.2–35.7) 94 50.0% (41.4–58.7) 278 <0.001
Dyslipidaemia other than low HDL6 16.9% (12.0–23.4) 28 13.1% (9.1–18.5) 42 10.4% (7.2–14.8) 57 0.21
UGANDA Entebbe municipality
(n = 205)
District towns (n = 278) Rural areas (n = 431)
High TC (�6.2 mmol/L) 6.3% (4.4–9.1) 13 5.2% (2.7–9.8) 15 3.6% (1.6–7.6) 13 0.20
High LDL-C (�4.1 mmol/L) 5.4% (3.3–8.6) 11 3.8% (1.4–9.6) 9 2.8% (1.2–6.3) 10 0.17
High apoB 8 14.7% (9.3–22.4) 30 10.7% (7.2–15.5) 34 11.9% (7.5–18.3) 41 0.42
Low HDL-C (<1 mmol/L) 12.7% (9.3–17.1) 26 16.4% (11.2–23.3) 51 31.5% (23.6–40.6) 147 <0.001
High triglycerides (�2.26 mmol/L) 6.8% (4.6–10.1) 14 10.7% (7.7–14.8) 24 9.6% (6.2–14.5) 38 0.56
High TC/HDL-C ratio (males >6.4 and females >5.6) 3.4% (2.0–5.8) 7 4.1% (2.2–7.5) 16 9.7% (6.8–13.6) 42 0.01
Any dyslipidaemia 7,9 31.7% (24.9–39.3) 65 31.5% (25.0–38.9) 90 43.5% (36.5–50.7) 187 0.05
Dyslipidaemia other than low HDL10 21.0% (15.6–27.6) 43 19.5% (14.9–25.1) 51 18.1% (12.6–25.3) 67 0.48
1Weighted estimates, adjusted for survey design with sampling weights applied because the probability of being sampled differed within strata.
295% confidence interval.
3Actual number of respondents, without sampling weights applied.
4p-values were calculated using unweighted data by logistic regression with location as a categorical variable to compare row variables across the 3 strata.
5apoB results are missing for 1 rural participant.
6Dyslipidemia results are missing for 1 rural participant.
7Dyslipidaemia defined as high TC, LDL-C, triglyceride or apoB, or low HDL-C.
8apoB results are missing for 1 Entebbe municipality, 4 district town and 14 rural participants.
9Dyslipidemia results are missing for 3 district town and 7 rural participants.
10Dyslipidemia other than HDL results are missing for 4 district town and 11 rural participants.
https://doi.org/10.1371/journal.pone.0223189.t003
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Table 4. Factors associated with low-density lipoprotein cholesterol, apolipoprotein B, high-density lipoprotein cholesterol and apolipoprotein A1 levels.
Factors associated with
LDL-C
Factors associated with
apoB
Factors associated with
HDL-C
Factors associated with
apoA1
n Mean Coefficient (95%
CI)1
Mean Coefficient (95%
CI)1
Mean Coefficient (95%
CI)1
Mean Coefficient (95%
CI)1
Fixed variables
Sex p<0.001 p<0.001 p<0.001 p = 0.007
Male 852 2.14 0 0.76 0 1.13 0 1.39 0
Female 1105 2.45 0.35 (0.28, 0.43) 0.86 0.11 (0.09, 0.14) 1.22 0.08 (0.05, 0.11) 1.43 0.05 (0.01, 0.08)
Age, years p<0.001 p<0.001 p = 0.01 p<0.001
<25 554 2.17 0 0.76 0 1.15 0 1.35 0
25–34 580 2.30 0.17 (0.07, 0.27) 0.81 0.05 (0.02, 0.09) 1.20 0.04 (-0.00, 0.09) 1.42 0.05 (0.00, 0.09)
35–44 322 2.41 0.32 (0.21, 0.43) 0.85 0.10 (0.06, 0.13) 1.17 0.04 (-0.02, 0.11) 1.42 0.06 (0.00, 0.11)
45+ 501 2.43 0.48 (0.35, 0.60) 0.88 0.16 (0.13, 0.19) 1.19 0.11 (0.05, 0.17) 1.48 0.14 (0.09, 0.19)
Other sociodemographic
variables1
Marital status p = 0.19 p = 0.19 p = 0.04 p = 0.008
Married/living as married 1167 2.32 0 0.83 0 1.18 0 1.43 0
Widowed/separated/divorced 344 2.38 -0.06 (-0.16, 0.03) 0.86 -0.00 (-0.04, 0.03) 1.19 -0.03 (-0.08, 0.02) 1.44 -0.03 (-0.07, 0.01)
Single 446 2.23 -0.08 (-0.20, 0.03) 0.78 -0.03 (-0.07, 0.00) 1.18 -0.05 (-0.10, -0.01) 1.35 -0.06 (-0.09, 0.02)
Education p = 0.01 p = 0.01 p = 0.007 p = 0.19
None/incomplete primary 662 2.15 0 0.78 0 1.11 0 1.38 0
Primary 633 2.32 0.11 (0.01, 0.20) 0.82 0.04 (0.01, 0.07) 1.16 0.04 (-0.00, 0.09) 1.42 0.03 (-0.01, 0.08)
Secondary or above 662 2.47 0.17 (0.05, 0.29) 0.86 0.04 (0.00, 0.08) 1.27 0.09 (0.03, 0.14) 1.43 0.04 (-0.01, 0.09)
Employment p = 0.01 p = 0.07 p = 0.81 p = 0.85
Self-employed 1183 2.25 0 0.81 0 1.15 0 1.41 0
Formal employment 286 2.56 0.16 (0.05, 0.28) 0.88 0.04 (0.01, 0.07) 1.23 0.01 (-0.06, 0.07) 1.43 -0.00 (-0.05, 0.05)
Not employed 488 2.32 0.01 (-0.10, 0.11) 0.82 -0.00 (-0.04, 0.03) 1.23 0.02 (-0.04, 0.07) 1.41 0.01 (-0.03, 0.05)
Monthly income, USD p = 0.005 p = 0.01 p = 0.57 p = 0.10
<38 1064 2.20 0 0.80 0 1.15 0 1.39 0
�38 829 2.48 0.14 (0.04, 0.23) 0.86 0.04 (0.01, 0.07) 1.23 0.01 (-0.03, 0.06) 1.45 0.03 (-0.01, 0.07)
Number of items owned p = 0.002 p = 0.001 p = 0.93 p = 0.99
0–1 219 2.14 -0.01 (-0.12, 0.09) 0.78 0.00 (-0.03, 0.04) 1.11 -0.01 (-0.07, 0.05) 1.39 -0.00 (-0.05, 0.05)
2–4 1183 2.27 0 0.80 0 1.18 0 1.41 0
5+ 555 2.48 0.14 (0.06, 0.22) 0.87 0.05 (0.02, 0.08) 1.21 0.00 (-0.04, 0.05) 1.42 -0.00 (-0.04, 0.04)
Water source p<0.001 p = 0.002 p = 0.51 p = 0.48
Tap in house/compound 733 2.53 0 0.89 0 1.28 0 1.47 0
Well 1047 2.12 -0.20 (-0.33, -0.08) 0.76 -0.07 (-0.12, -0.03) 1.09 -0.01 (-0.08, 0.05) 1.36 -0.02 (-0.07, 0.03)
Other 177 2.60 0.08 (-0.13, 0.28) 0.85 0.01 (-0.05, 0.07) 1.30 0.05 (-0.07, 0.16) 1.50 0.02 (-0.05, 0.09)
Behavioural variables
Smoking status p = 0.006 p<0.001 p = 0.15 p = 0.18
Current 178 2.00 -0.21 (-0.36, -0.07) 0.74 -0.06 (-0.10, -0.03) 1.21 0.06 (-0.01, 0.13) 1.47 0.04 (-0.01, 0.10)
Ex-smoker 149 2.14 -0.18 (-0.34, -0.02) 0.77 -0.06 (-0.11, -0.02) 1.18 0.04 (-0.04, 0.12) 1.45 0.04 (-0.03, 0.10)
Never 1629 2.36 0 0.83 0 1.18 0 1.40 0
Alcohol consumption p = 0.08 p = 0.24 p<0.001 p<0.001
Never drinker 1022 2.34 0 0.81 0 1.14 0 1.37 0
Ex-drinker 451 2.28 -0.03 (-0.13, 0.06) 0.82 -0.01 (-0.04, 0.02) 1.13 0.01 (-0.03, 0.05) 1.39 0.01 (-0.03, 0.04)
Healthy drinker 336 2.26 -0.13 (-0.23, -0.03) 0.83 -0.03 (-0.07, -0.00) 1.28 0.11 (0.03, 0.19) 1.48 0.09 (0.03, 0.15)
Unhealthy drinker 146 2.40 -0.07 (-0.21, 0.08) 0.84 -0.01 (-0.05, 0.04) 1.40 0.23 (0.15, 0.32) 1.66 0.26 (0.19, 0.33)
Usual mode of transport p = 0.05 p = 0.006 p = 0.60 p = 0.39
(Continued)
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Discussion
Our study is the first multi-national, community-based survey of dyslipidemia and cardiovas-
cular risk scores in Africa. The distribution of dyslipidemias and cardiovascular risk was simi-
lar between Uganda and Tanzania and differed between rural and urban areas in both
countries. We found that 30–50% of the population in the study areas meet the internation-
ally-recognized Adult Treatment Panel III criteria for dyslipidemia but only few (<10%) have
high 10-year cardiovascular risk scores. The relatively higher prevalence of dyslipidemia found
in our study compared to prior studies is probably because we tested for a broad spectrum of
dyslipidemias compared to prior studies [7, 31, 32].
Elevated levels of LDL-C were rare in our study population, occurring in <10% of popula-
tion all study strata. Similarly low LDL-C levels have been reported in African Americans liv-
ing in the United States [33], suggesting a possible genetic protection. However, LDL-C levels
were relatively higher in urban than rural areas, as previously described in West Africa [11,
33]. Female gender, older age and obesity were all consistently associated with higher LDL-C
and apoB levels, as previously reported in ecological studies [4]. The observed associations
could partly be explained by genetic predisposition such GYP19A1 rs10046 polymorphism.
This gene variant has been associated with high apoB levels among non-obese females and
obese men [34]. Association of LDL-C and apoB with older age may reflect cumulative effect
Table 4. (Continued)
Factors associated with
LDL-C
Factors associated with
apoB
Factors associated with
HDL-C
Factors associated with
apoA1
n Mean Coefficient (95%
CI)1
Mean Coefficient (95%
CI)1
Mean Coefficient (95%
CI)1
Mean Coefficient (95%
CI)1
Walk 916 2.28 0 0.81 0 1.19 0 1.41 0
Bicycle 438 2.09 -0.06 (-0.17, 0.04) 0.75 -0.02 (-0.05, 0.01) 1.06 -0.01 (-0.06, 0.03) 1.36 -0.02 (-0.06, 0.03)
Vehicle 603 2.54 0.10 (-0.02, 0.22) 0.89 0.05 (0.01, 0.09) 1.25 -0.02 (-0.07, 0.03) 1.45 -0.02 (-0.06, 0.01)
Anthropometric variables
BMI category p<0.001 p<0.001 p<0.001 p = 0.10
Underweight 185 1.89 -0.25 (-0.36, -0.14) 0.70 -0.05 (-0.09, -0.02) 1.16 0.01 (-0.07, 0.09) 1.38 0.00 (-0.06, 0.06)
Normal 1309 2.19 0 0.78 0 1.18 0 1.40 0
Overweight 300 2.71 0.23 (0.11, 0.36) 0.96 0.06 (0.01, 0.11) 1.20 -0.06 (-0.12, 0.00) 1.47 -0.00 (-0.05, 0.04)
Obese 149 3.12 0.48 (0.26, 0.71) 1.09 0.15 (0.07, 0.23) 1.17 -0.15 (-0.21, -0.09) 1.45 -0.06 (-0.11, -0.01)
Abdominal obesity2 p = 0.03 p<0.001 p = 0.10 p = 0.13
No 1443 2.15 0 0.76 0 1.18 0 1.39 0
Yes 511 2.77 0.12 (0.01, 0.24) 0.99 0.09 (0.05, 0.13) 1.18 -0.05 (-0.12, 0.01) 1.47 0.04 (-0.01, 0.09)
Chronic disease variables
HIV p = 0.01 p = 0.73 p<0.001 p<0.001
Negative 1760 2.33 0 0.82 0 1.19 0 1.42 0
Positive and off treatment 125 2.16 -0.22 (-0.38, -0.06) 0.82 -0.02 (-0.07, 0.04) 0.96 -0.29 (-0.37, -0.21) 1.25 -0.22 (-0.29, -0.16)
Positive and on treatment 62 2.20 -0.12 (-0.33, 0.08) 0.82 -0.01 (-0.09, 0.06) 1.25 0.04 (-0.11, 0.18) 1.44 0.01 (-0.10, 0.11)
Hypertension p<0.001 p = 0.004 p = 0.02 p<0.001
Negative 1573 2.24 0 0.80 0 1.17 0 1.39 0
Positive and off treatment 355 2.56 0.23 (0.12, 0.33) 0.90 0.06 (0.02, 0.09) 1.22 0.06 (0.01, 0.12) 1.51 0.08 (0.04, 0.12)
Positive and on treatment 29 3.21 0.26 (-0.14, 0.67) 1.16 0.08 (-0.07, 0.24) 1.29 0.09 (-0.00, 0.18) 1.47 0.03 (-0.08, 0.13)
Note: “0” indicates the reference group. Results of the variables with p�0.05 in the final models are shown in bold.
195% confidence interval
2abdominal obesity was defined as waist circumference >94 cm for men and >80 cm for women.
https://doi.org/10.1371/journal.pone.0223189.t004
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of exposure to predisposing risk factors to high blood lipid levels including physical inactivity
[35] and dietary habits [36]. Reducing LDL-C levels with HMG Co-A reductase inhibitors (i.e.
statins) has consistently been shown to reduce both cardiovascular and overall mortality risk
[37], but very few Africans in need of treatment are currently receiving it [31, 38]. Health ser-
vices should be strengthened to include dyslipidemia management, particularly in urban areas
and for older adults with obesity [39, 40].
Low HDL-C was the most common dyslipidemia, occurring in 30–40% of the rural popula-
tion. Unlike other dyslipidemias, low HDL-C levels often occurred alone (without other asso-
ciated dyslipidemias). Although a high prevalence of low HDL-C has previously been reported
in rural communities of other African countries [32, 41], the clinical importance of this abnor-
mality remains uncertain. In North American and European populations, adults with low
HDL-C have a higher incidence of coronary heart disease [42]. No prospective data has been
published from Africa. The fact that lower HDL-C levels correlated with lower LDL-C levels in
our population suggests that production of HDL-C is likely low because of the low need for
cholesteryl ester reverse transport. This hypothesis is supported by the relatively high apoA1
levels in our study population compared to prior studies in Africa [1, 38]. Alternatively, low
HDL-C and apoA1 levels may be related to insufficient macronutrient or micronutrient (par-
ticularly B12 or zinc) intake [13, 43]. Further research is warranted.
We also reported Framingham 10-year cardiovascular risk scores using 2 formulae: with
and without lipids. These formulae yielded similar results in all strata, supporting the notion
that simple clinical risk scores without lipid measurement could be sufficient for identifying
Table 5. Framingham cardiovascular risk scores.
Weighted %1 (95% CI)2 n3 Weighted %1 (95% CI)2 n3 Weighted %1(95% CI)2 n3 P-value4
TANZANIA Mwanza municipality (n = 170) District towns (n = 326) Rural areas (n = 547)
Framingham 10-year cardiovascular risk category (without lipid results)5 0.06
Low (<10%) 86.0% (80.2–90.2) 147 89.4% (84.9–92.7) 291 82.6% (77.9–86.4) 446
Intermediate (10–19%) 8.4% (4.5–15.3) 13 7.1% (4.9–10.2) 23 10.3% (7.6–13.7) 56
High (�20%) 5.6% (2.7–11.1) 9 3.5% (2.1–5.9) 12 7.1% (4.9–10.2) 41
Framingham 10-year cardiovascular risk category (with lipid results) 0.05
Low (<10%) 88.1% (81.4–92.6) 151 90.7% (86.2–93.8) 295 84.4% (80.2–87.9) 458
Intermediate (10–19%) 7.6% (3.7–15.2) 12 5.7% (3.8–8.5) 19 8.8% (6.4–11.9) 50
High (�20%) 4.3% (2.2–8.0) 7 3.6% (1.9–6.7) 12 6.8% (4.7–9.7) 39
UGANDA Entebbe municipality (n = 205) District towns (n = 278) Rural areas (n = 431)
Framingham 10-year cardiovascular risk category (without lipid results)6 0.01
Low (<10%) 90.0% (84.2–93.8) 180 88.9% (83.4–92.7) 246 80.7% (72.7–86.7) 344
Intermediate (10–19%) 4.5% (2.3–8.7) 9 4.1% (2.3–7.2) 14 8.2% (5.8–11.4) 34
High (�20%) 5.5% (3.0–10.0) 11 7.0% (3.7–12.9) 15 11.2% (6.7–18.0) 52
Framingham 10-year cardiovascular risk category (with lipid results) 0.006
Low (<10%) 91.2% (86.5–94.4) 187 90.4% (86.3–93.4) 254 82.7% (76.1–87.7) 353
Intermediate (10–19%) 2.9% (1.9–4.4) 6 1.5% (0.6–4.1) 10 7.9% (5.7–10.8) 35
High (�20%) 5.9% (3.3–10.1) 12 8.0% (4.7–13.3) 14 9.4% (6.3–14.0) 43
1Weighted estimates, adjusted for survey design with sampling weights applied because the probability of being sampled differed within the strata.
295% confidence interval.
3Actual number of respondents, without sampling weights applied.
4p-values were calculated using unweighted data by ordinal logistic regression with location as a categorical variable.
5Framingham risk scores results are missing for 1 Mwanza municipality and 2 rural participants (missing weight and/or height).
6Framingham risk scores results are missing for 5 Entebbe municipality, 3 district town and 1 rural participants (missing weight and/or height).
https://doi.org/10.1371/journal.pone.0223189.t005
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those with high cardiovascular risk in resource-limited countries in Africa [44]. Nearly all
adults with high cardiovascular risk scores were older (>55 years of age). Therefore, screening
for cardiovascular risk in Africa should begin with this group. Identifying adults with high car-
diovascular risk is clinically important because lipid-lowering drugs have been shown to be
cost-effective in this group [45].
Our study has limitations. Although we used 10-year Framingham risk equation in this
study, it has not been validated prospectively in African populations. Development and valida-
tion of a region-specific risk estimation equation is needed.
In conclusion, dyslipidemias are common in both urban and rural populations in Tanzania
and Uganda. Low HDL-C was the most commonly observed dyslipidemia, affecting nearly
one third of rural populations. Elevated LDL-C was relatively rare but was more prevalent in
older, overweight, urban dwelling females of higher socioeconomic status. Although popula-
tion cardiovascular risk scores both with and without lipids were generally low, many adults
>55years had high cardiovascular risk scores. Health services designed and equipped to diag-
nose and treat dyslipidemia are urgently needed.
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